This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Dawson-Hughes B et al. (2005) Estimates of optimal vitamin D status. Osteoporosis Int 16: 713–716
Grant AM et al. (2005) Oral vitamin D3 and calcium for secondary prevention of low trauma fractures in elderly people (randomised evaluation of calcium or vitamin D, RECORD): a randomised placebo controlled trial. Lancet 365: 1621–1628
Porthouse J et al. (2005) Randomised controlled trial of supplementation with calcium and cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ 330: 1003–1006
Jackson RD et al. (2006) Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 354: 669–683
Trivedi DP et al. (2003) Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 326: 469–472
Acknowledgements
The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Dr Hosking is conducting clinical trials in osteoporosis and other metabolic bone diseases which are, or have been, funded by Merck Sharp and Dohme, Novartis, Nycomed, Roche/GSK and Lilly. He also receives honoraria as a speaker at medical symposia for the above companies.
Rights and permissions
About this article
Cite this article
Hosking, D. Are calcium supplements necessary in vitamin-D-replete individuals?. Nat Rev Endocrinol 2, 310–311 (2006). https://doi.org/10.1038/ncpendmet0194
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpendmet0194